1. Home
  2. IPWR vs LIXT Comparison

IPWR vs LIXT Comparison

Compare IPWR & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ideal Power Inc.

IPWR

Ideal Power Inc.

HOLD

Current Price

$3.47

Market Cap

26.3M

Sector

Industrials

ML Signal

HOLD

Logo Lixte Biotechnology Holdings Inc.

LIXT

Lixte Biotechnology Holdings Inc.

HOLD

Current Price

$3.56

Market Cap

25.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPWR
LIXT
Founded
2007
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.3M
25.4M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
IPWR
LIXT
Price
$3.47
$3.56
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$10.75
N/A
AVG Volume (30 Days)
58.1K
81.8K
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,136.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3,233.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.76
$0.64
52 Week High
$8.62
$6.26

Technical Indicators

Market Signals
Indicator
IPWR
LIXT
Relative Strength Index (RSI) 46.46 33.67
Support Level $2.76 $3.80
Resistance Level $3.36 $4.14
Average True Range (ATR) 0.31 0.29
MACD 0.05 -0.04
Stochastic Oscillator 60.40 7.14

Price Performance

Historical Comparison
IPWR
LIXT

About IPWR Ideal Power Inc.

Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

Share on Social Networks: